Immunodiagnostics Market Overview
Immunodiagnostics is a diagnostic procedure that relies heavily on the antigen-antibody response as a key mechanism of detection. Antibodies that are specific for a particular antigen can be coupled with a radiolabel, fluorescent label, or color-forming enzyme and used as a probe to detect it. Because of the speed, accuracy, and simplicity of such testing, quick procedures for diagnosing disease, microorganisms, and even illegal narcotics in vivo have been developed. Immunodiagnostics Market accounted for US$ 19.30 billion in 2020 and is estimated to be US$ 39.69 billion by 2030 and is anticipated to register a CAGR of 7.50%.
Impact of Covid-19 pandemic on market
The Saudi Arabian government signed a memorandum of understanding with the government of COVID-19 virus outbreak was first observed in December 2019 in Wuhan (China), and it has since spread to over 100 countries worldwide, with the World Health Organization (WHO) declaring it a public health emergency. COVID-19's global ramifications are being seen in a variety of markets. Despite the fact that the healthcare sector has seen SARS, H1N1, and other epidemics in recent years, the severity of COVID-19 has complicated the issue due to its mechanism of transmission. Since its breakout, North America has seen an increase in the number of COVID-19 cases.
Immunodiagnostics Market Dynamics
Increased prevalence of infectious diseases
The increased prevalence of infectious diseases, cardiovascular diseases, cancer, gastrointestinal diseases, and other chronic diseases, as well as changes in demography and lifestyle, are likely to drive the growth of the immunodiagnostics market over the forecast period. Furthermore, technological advancements in diagnosis kits, assays, and analyzers, as well as an increase in awareness of preventative health measures among patients and medical professionals, are a few of the factors expected to drive the growth of the immunodiagnostics market. The rigorous governing circumstances, on the other hand, are one of the reasons that are expected to restrict the expansion of the immunodiagnostics market in the near future.
Furthermore, technical advancements in diagnosis kits, assays, and analyzers, as well as increased awareness of preventive health measures among patients and medical professionals, generate demand for immunodiagnostics goods, driving growth. However, a number of obstacles are predicted to hinder market growth. The impact of the drivers is projected to be greater than the impact of the constraints. Furthermore, an increase in the impact of the drivers and restraints is expected to open up new market opportunities for key companies manufacturing immunodiagnostics products, particularly kits and assays.
Immunodiagnostics Market Segmentation
Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.
The Global Immunodiagnostics Market report segments the market on the basis of type, technology, application and region.
On the basis of Type, the Global Immunodiagnostics Market is segmented into Immunodiagnostic Instruments, Immunoassays. Based on Technology the market is segmented into Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test and Others. Based on Application the market is segmented into Oncology and Endocrinology, Hepatitis and Retrovirus Testing, Infectious Disease Testing, GI Stool Testing.
Regional Insights:
On region the Global Immunodiagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the immunodiagnostics market due to increase in the need for immunodiagnostics tests, an increase in the older population, and an increase in the occurrences of chronic and infectious diseases. Furthermore, an increase in customer awareness of early disease management will encourage them to undergo frequent tests and check-ups, boosting the growth of the immunodiagnostics market in the area during the projection period. Because of increased investments by several major players, a rise in awareness, advancements in health care infrastructure, and appropriate legislative changes, Asia Pacific is expected to witness considerable growth in the immunodiagnostics market.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2029 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2029 |
|
Market Segmentation |
By Type - Immunodiagnostic Instruments, Immunoassays By Technology – Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test and Others By Application – Oncology and Endocrinology, Hepatitis and Retrovirus Testing, Infectious Disease Testing, GI Stool Testing |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Immunodiagnostics Market report based on Type, Technology, Application and Region.
Recent Highlights:
- Thermo Fisher Scientific bought Mesa Biotech (US) in February 2021 to enhance the benefits of molecular diagnostics at the point of care.
- Abbott Laboratories will introduce the ID NOW COVID-19 Test in March 2020.
Global Immunodiagnostics Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Immunodiagnostics Market Key Players
The key players operating in the Global Immunodiagnostics Market includes Abbott Laboratories, Immunodiagnostic Systems Holdings Plc (IDS), DiaSorin S.p.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Siemens AG, Sysmex Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and Arkray, Inc.
Immunodiagnostics Market Company Profile
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Immunodiagnostic Systems Holdings Plc (IDS)
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- DiaSorin S.p.A.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- F. Hoffmann-La Roche Ltd
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Siemens AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Sysmex Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Danaher Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bio-Rad Laboratories, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Immunodiagnostics Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for immunodiagnostics Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By Technology
- Market Snippet, By Application
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Immunodiagnostics Market, By Type, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Immunodiagnostic Instruments
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Immunoassays
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Immunodiagnostics Market, By Technology, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Enzyme-Linked Immunosorbent Assay
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Chemiluminescence
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Immunoassay
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Fluorescent Immunoassay
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Radioimmunoassay
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Rapid Test
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Immunodiagnostics Market, By Application, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Oncology and Endocrinology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Hepatitis and Retrovirus Testing
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Infectious Disease Testing
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- GI Stool Testing
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Immunodiagnostics Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Immunodiagnostic Systems Holdings Plc (IDS)
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- DiaSorin S.p.A.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- F. Hoffmann-La Roche Ltd
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Siemens AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Sysmex Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Danaher Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bio-Rad Laboratories, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The Global Immunodiagnostics Market report segments the market on the basis of type, technology, application, and region.
The increased prevalence of infectious diseases, cardiovascular diseases, cancer, gastrointestinal diseases, and other chronic diseases, as well as changes in demography and lifestyle, are likely to drive the growth of the immunodiagnostics market over the forecast period.
North America dominates the immunodiagnostics market due to increase in the need for immunodiagnostics tests, an increase in the older population, and an increase in the occurrences of chronic and infectious diseases.
The key players operating in the Global Immunodiagnostics Market includes Abbott Laboratories, Immunodiagnostic Systems Holdings Plc (IDS), DiaSorin S.p.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Siemens AG, Sysmex Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and Arkray, Inc.